ADGRG1 and breast cancer: Genomic and proteomic studies have indicated that GPR56 is overexpressed and plays a pro-carcinogenic role in various cancers, including breast cancer, epithelial ovarian cancer, esophageal cancer, and colorectal cancer [17, 19, 21, 29].